Literature DB >> 24929292

Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.

Ricardo Augusto Massarico Serafim1, José Eduardo Gonçalves2, Felipe Pereira de Souza3, Ana Paula de Melo Loureiro3, Silvia Storpirtis2, Renata Krogh4, Adriano Defini Andricopulo4, Luiz Carlos Dias5, Elizabeth Igne Ferreira6.   

Abstract

Hybrid bioisoster derivatives from N-acylhydrazones and furoxan groups were designed with the objective of obtaining at least a dual mechanism of action: cruzain inhibition and nitric oxide (NO) releasing activity. Fifteen designed compounds were synthesized varying the substitution in N-acylhydrazone and in furoxan group as well. They had its anti-Trypanosoma cruzi activity in amastigotes forms, NO releasing potential and inhibitory cruzain activity evaluated. The two most active compounds (6, 14) both in the parasite amastigotes and in the enzyme contain the nitro group in para position of the aromatic ring. The permeability screening in Caco-2 cell and cytotoxicity assay in human cells were performed for those most active compounds and both showed to be less cytotoxic than the reference drug, benznidazole. Compound 6 was the most promising, since besides activity it showed good permeability and selectivity index, higher than the reference drug. Thereby the compound 6 was considered as a possible candidate for additional studies.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-Trypanosoma cruzi compounds; Bioisosters; Furoxan derivatives; Molecular hybrids; N-acylhydrazone derivatives; Nitric oxide donor groups

Mesh:

Substances:

Year:  2014        PMID: 24929292     DOI: 10.1016/j.ejmech.2014.05.077

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

Review 1.  Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties.

Authors:  Soraya S Santos; Rodrigo V Gonzaga; Cauê B Scarim; Jeanine Giarolla; Marina C Primi; Chung M Chin; Elizabeth I Ferreira
Journal:  Front Chem       Date:  2022-02-14       Impact factor: 5.221

2.  Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics.

Authors:  Ivani Pauli; Celso de O Rezende; Brian W Slafer; Marco A Dessoy; Mariana L de Souza; Leonardo L G Ferreira; Abraham L M Adjanohun; Rafaela S Ferreira; Luma G Magalhães; Renata Krogh; Simone Michelan-Duarte; Ricardo Vaz Del Pintor; Fernando B R da Silva; Fabio C Cruz; Luiz C Dias; Adriano D Andricopulo
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

3.  Synthesis of bicyclic 1,4-thiazepines as novel anti-Trypanosoma brucei brucei agents.

Authors:  Franco Vairoletti; Andrea Medeiros; Pablo Fontán; Jennifer Meléndrez; Carlos Tabárez; Gustavo Salinas; Jaime Franco; Marcelo A Comini; Jenny Saldaña; Vojtech Jancik; Graciela Mahler; Cecilia Saiz
Journal:  Medchemcomm       Date:  2019-06-11       Impact factor: 3.597

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.